These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10667036)

  • 1. Clinical and pharmacological aspects of accidental triamcinolone acetonide overdosage: a case study.
    Schweitzer DH; Le-Brun PP; Krishnaswami S; Derendorf H
    Neth J Med; 2000 Jan; 56(1):12-6. PubMed ID: 10667036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients.
    Kumar S; Singh RJ; Reed AM; Lteif AN
    Pediatrics; 2004 Jun; 113(6):1820-4. PubMed ID: 15173517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's syndrome in postburn children following intralesional triamcinolone injection.
    Ritota PC; Lo AK
    Ann Plast Surg; 1996 May; 36(5):508-11. PubMed ID: 8743662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
    Knych HK; Vidal MA; Casbeer HC; McKemie DS
    Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey.
    Fredman R; Tenenhaus M
    Burns; 2013 Jun; 39(4):549-57. PubMed ID: 23092701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
    Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's syndrome: complication of triamcinolone injection for urethral strictures in children.
    Augspurger RR; Wettlaufer JN
    J Urol; 1980 Jun; 123(6):932-3. PubMed ID: 7382013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration.
    Gondwe JS; Davidson JE; Deeley S; Sills J; Cleary AG
    Rheumatology (Oxford); 2005 Nov; 44(11):1457-8. PubMed ID: 16244103
    [No Abstract]   [Full Text] [Related]  

  • 10. Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection.
    Jansen TL; Van Roon EN
    Neth J Med; 2002 Apr; 60(3):151-3. PubMed ID: 12164373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
    Schott S; Schnauder G; Müssig K
    Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and persistent iatrogenic Cushing's syndrome after a single dose of triamcinolone acetonide.
    Iglesias P; González J; Díez JJ
    J Endocrinol Invest; 2005 Dec; 28(11):1019-23. PubMed ID: 16483182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration.
    Rohatagi S; Hochhaus G; Mollmann H; Barth J; Galia E; Erdmann M; Sourgens H; Derendorf H
    J Clin Pharmacol; 1995 Dec; 35(12):1187-93. PubMed ID: 8750370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of mifepristone in the treatment of Cushing's syndrome.
    Carroll T; Findling JW
    Drugs Today (Barc); 2012 Aug; 48(8):509-18. PubMed ID: 22916338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the effects of local treatment with glucocorticoids only local?
    van Tuyl SA; Slee PH
    Neth J Med; 2002 Apr; 60(3):130-2. PubMed ID: 12164369
    [No Abstract]   [Full Text] [Related]  

  • 17. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir.
    Yombi JC; Maiter D; Belkhir L; Nzeusseu A; Vandercam B
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S79-82. PubMed ID: 18827959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars.
    Finken MJ; Mul D
    Eur J Pediatr; 2010 Sep; 169(9):1147-9. PubMed ID: 20186428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.
    Soma LR; Uboh CE; You Y; Guan F; Boston RC
    Am J Vet Res; 2011 Sep; 72(9):1234-42. PubMed ID: 21879982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration.
    Argenti D; Shah B; Heald D
    J Clin Pharmacol; 2000 May; 40(5):516-26. PubMed ID: 10806605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.